- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT03254979
Optimizing the Primary Prevention of Type-2 Diabetes in Primary Health Care (PREDIAPS)
How to Engage Primary Health Care Providers in an Inter-professional Collaborative Modeling Process for the Optimization of Type-2 Diabetes Primary Prevention: a Randomized Hybrid Implementation Trial
RATIONALE The translation into clinical practice of Primary Care (PHC) of effective and sustainable interventions to prevent of type-2 diabetes (T2D) remains an unresolved challenge. Leadership, active involvement of professionals, facilitation and adaptation to the local context and their determinants are known to be key components in the success of implementation strategies that seek to optimize clinical practice. However, one of the areas in which there is still no evidence is related to the effectiveness of different strategies to engage healthcare professionals in such innovation processes. Especially in real-world Primary Care clinical contexts characterized by work overload and limited time, with marked differentiation of professional status, both at the level of identity and competency.
OBJECTIVES To assess the effect of PHC providers engagement procedure in the creation and execution of a facilitated collaborative modelling process, in the adoption, reach, implementation and effectiveness of the recommended clinical practice for the prevention of type-2 Diabetes
METHODOLOGY
Randomized cluster hybrid trial in which 9 PHC centres from Osakidetza will be allocated to two different strategies to engage professionals and create an inter-professional collaborative practice directed by a local leader and an external facilitator, to optimize the integration of a T2D primary prevention program:
- A strategy focused on the sequential activation: started in nursing, which finally manages to involve the whole center
- A global strategy with the participation of all professionals from the beginning
All centres and PHC professionals will receive training on current guidelines and scientific evidence in primary prevention of T2D and effective interventions to promote healthy lifestyles. Headed by a local leader and an external facilitator, centres will conduct a collaborative structured process to model and adapt the intervention and its implementation to the specific context of professionals and centres, and the determinants of T2D prevention practice. One of the groups will perform this strategy globally, promoting the cooperation of all health professionals from the beginning. The other will perform it sequentially, centred first in nursing, who will lately seek the pragmatic cooperation of physicians and other professionals.
All patients without diabetes aged ≥30 years old who attend at least once in collaborating centres at high risk of developing T2DM (FINDRISC> = 14 points and / or intermediate hyperglycaemia) will be eligible for program inclusion. The main outcome measures focus on observed changes in T2DM prevention clinical practice at centre level after 12 and 24 months, as a result of the implementation of one or another engagement strategy. Secondary outcomes will compare their clinical effectiveness in changing exposed eligible patients' main cardio-metabolic risk factors (Weight, BMI, Cholesterol, Glucose, Triglycerides) and lifestyles behaviours (physical activity and diet) after 12 months.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
-
Bilbao, Spanien
- Primary Care Research Unit of Bizkaia, OSAKIDETZA
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- All patients without diabetes aged ≥30 years old who attend at least once in collaborating centres at high risk of developing T2DM (Body Mass Index >=25 or intermediate hyperglycaemia) will be eligible for program inclusion.
Exclusion Criteria:
-
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Sundhedstjenesteforskning
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Dobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Sequential engagement
Inter-professional collaborative practice directed by a local leader and an external facilitator to optimize the integration of a T2D primary prevention recommended clinical intervention.
In this group, a sequential engagement of professional categories, initiated in nursing, which finally involves the whole professional groups of the center (eg.
physicians, etc), will be followed
|
3 actions for the prevention of DM2 in the clinical setting are recommended:
|
|
Aktiv komparator: Global engagement
Inter-professional collaborative practice directed by a local leader and an external facilitator to optimize the integration of a T2D primary prevention recommended clinical intervention.
In this group, a global strategy of engagement with the participation of all professionals from the beginning, will be followed
|
3 actions for the prevention of DM2 in the clinical setting are recommended:
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Implementation of the recommended clinical intervention by health care porfessionals
Tidsramme: 12 months
|
The proportion of non-diabetic patients at high risk of developing DM2 exposed to the recommended intervention actions : assessing habits, personalized advice, prescription of lifestyle change plans and follow-up
|
12 months
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Lifestyle change at patient level
Tidsramme: 12 months
|
Proportion of exposed patients who change their habits (physical activity and diet) and lose 5% of their body weight
|
12 months
|
Samarbejdspartnere og efterforskere
Sponsor
Publikationer og nyttige links
Generelle publikationer
- Sanchez A, Pablo S, Garcia-Alvarez A, Dominguez S, Grandes G; PREDIAPS Group. Effectiveness of two procedures for deploying a facilitated collaborative modeling implementation strategy-the PVS-PREDIAPS strategy-to optimize type 2 diabetes prevention in primary care: the PREDIAPS cluster randomized hybrid type II implementation trial. Implement Sci. 2021 May 27;16(1):58. doi: 10.1186/s13012-021-01127-x.
- Sanchez A, Rogers HL, Pablo S, Garcia E, Rodriguez I, Flores MA, Galarza O, Gaztanaga AB, Martinez PA, Alberdi E, Resines E, Llarena AI, Grandes G; PREDIAPS Group. Fidelity evaluation of the compared procedures for conducting the PVS-PREDIAPS implementation strategy to optimize diabetes prevention in primary care. BMC Fam Pract. 2021 Feb 11;22(1):34. doi: 10.1186/s12875-021-01378-z.
- Sanchez A, Grandes G, Pablo S, Espinosa M, Torres A, Garcia-Alvarez A; PREDIAPS Group. Engaging primary care professionals in collaborative processes for optimising type 2 diabetes prevention practice: the PREDIAPS cluster randomised type II hybrid implementation trial. Implement Sci. 2018 Jul 11;13(1):94. doi: 10.1186/s13012-018-0783-0.
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- PI15/00350
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
produkt fremstillet i og eksporteret fra U.S.A.
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Randomiseret kontrolleret forsøg
-
Universiti Putra MalaysiaUniversity of LahoreAfsluttetTeenager | Sundhedsfremme | Tandplak | Cluster Randomized Trial | Mundhygiejne, mundsundhed | PakistanPakistan
-
Women's College HospitalQueen's UniversityUkendtFeasibility Randomized Control TrialCanada
-
Global and Sexual Health (GloSH)AfsluttetMentalt helbred | Vold i hjemmet | Intim partnervold | Intervention | Sekundær forebyggelse | Problem Management Plus | Cluster Randomized TrialNepal
-
Jinling Hospital, ChinaIkke rekrutterer endnuIntrakraniel aneurisme | CT angiografi | Cluster Randomized Trial | AI (kunstig intelligens)
-
Istanbul UniversityAktiv, ikke rekrutterende
-
Maastricht University Medical CenterUkendt
-
Kun SunBill and Melinda Gates FoundationAfsluttetMedfødt hjertesygdom (CHD) | Cluster Randomized Trial | Auskultation til klinisk evaluering | Screeningsværktøj | Kunstig intelligens (AI)Kina
-
Pontificia Universidad Catolica de ChileRekrutteringTarget Controlled Infusion (TCI) | Remifentanil forbrug | Kunstig intelligens (AI) | NociceptionChile
-
Guangzhou General Hospital of Guangzhou Military...AfsluttetElektiv kirurgi | Target Controlled Infusion (TCI) | Skadelige Stimuli | Tracheal IntubationsstimulationKina
-
Unity Health TorontoAfsluttet
Kliniske forsøg med Healthy lifestyle prescription
-
Hospices Civils de LyonAfsluttetPotentielt upassende medicinFrankrig
-
Pavol Jozef Safarik UniversityUniversity of GroningenTrukket tilbage
-
Rush University Medical CenterAfsluttetDepression | AngstForenede Stater
-
Baylor College of MedicineAfsluttetFedmeForenede Stater
-
Human Development Research Foundation, PakistanUniversity of Liverpool; Shifa Tameer-e-Millat UniversityAfsluttetDepression, postpartum | Perinatal depressionPakistan
-
Oklahoma State University Center for Health SciencesUniversity of Oklahoma; Osage NationAfsluttetBlodtryk | Fødevareusikkerhed | Overvægt eller fedme | Kost, sund | HelbredsstatusForenede Stater
-
The University of Texas at ArlingtonUniversity of South Florida; Center for Transportation, Equity, Decisions...AfsluttetMangel på ressourcer | Mangel på mobilitetForenede Stater
-
University of Wisconsin, MadisonAfsluttetPsykisk nød | Ensomhed | Depression, angstForenede Stater
-
University of Wisconsin, MadisonAfsluttet
-
Noom Inc.AfsluttetVægttab | Opførsel, sundhedForenede Stater